Australia seems poised to experience innovative therapy for excess weight: Retatrutide. This dual molecule – acting on both GLP-1 and GIP receptors – has remarkable results in clinical trials, pointing to considerable drops in body fat. While availability remains with the Therapeutic Goods Admini